{"database": "lobbying", "table": "lobbying_activities", "rows": [[953830, "bbbb3e4f-05ff-4b79-a16d-bf5b0ebf9016", "Q2", "WILLIAMS AND JENSEN, PLLC", 41454, "BAYER CORPORATION", 2010, "second_quarter", "HCR", "Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; \n\n340 B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; \n\nAuthorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; \n\nDrug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; \n\nPrescription drug advertising; \n\nFederal preemption for prescription drugs; \n\nLegislation affecting telemedicine; and \n\nLegislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2010-07-15T08:49:40.747000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["953830"], "units": {}, "query_ms": 23.59469106886536, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}